Glioblastoma Multiforme Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
I
Recruiting
  • Solid Tumor
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden Hospital NHS Foundation Trust
2022-03-31
Mar 31, 2022
N
Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
K
Recruiting
  • Advanced Cancer
  • +3 more
  • EV3D Assay
  • Little Rock, Arkansas
  • +8 more
2022-03-30
Mar 30, 2022
U
Terminated
  • Glioblastoma Multiforme
  • +3 more
  • Gainesville, Florida
  • +1 more
2022-03-31
Mar 31, 2022
N
Recruiting
  • Glioblastoma Multiforme
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    A
    Not yet recruiting
    • Glioblastoma Multiforme
    • +3 more
    • P140K-MGMT
    • +5 more
    • Bethesda, Maryland
    • +1 more
    2022-04-05
    Apr 5, 2022
    A
    Recruiting
    • Glioblastoma Multiforme
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    2022-03-28
    Mar 28, 2022
    S
    Recruiting
    • High Grade Glioma
    • Glioblastoma Multiforme
    • Saint Louis, Missouri
    • +4 more
    2022-04-04
    Apr 4, 2022
    S
    Completed
    • Acute Myeloid Leukemia
    • +8 more
    • DSP-7888 Dosing Emulsion
    • Denver, Colorado
    • +7 more
    2022-04-04
    Apr 4, 2022
    K
    Recruiting
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +17 more
    2022-04-01
    Apr 1, 2022
    S
    Recruiting
    • Glioblastoma Multiforme
    • Stanford, California
    • +1 more
    2022-04-01
    Apr 1, 2022
    I
    Recruiting
    • Glioblastoma Multiforme
    • Regorafenib 40 MG Oral Tablet [STIVARGA]
    • Acquaviva Delle Fonti, BA, Italy
    • +28 more
    2022-03-31
    Mar 31, 2022
    I
    Active, not recruiting
    • Glioblastoma Multiforme
    • Castellana Grotte, BA, Italy
    • +9 more
    2022-03-31
    Mar 31, 2022
    U
    Active, not recruiting
    • Glioblastoma Multiforme
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    2022-03-15
    Mar 15, 2022
    B
    Not yet recruiting
    • Glioblastoma Multiforme
    • Recurrent Glioblastoma
    • TheraSphere GBM
    • (no location specified)
    2022-03-29
    Mar 29, 2022
    N
    Recruiting
    • Glioblastoma
    • +3 more
    • Phoenix, Arizona
      St. Joseph's Hospital and Medical Center
    2022-03-10
    Mar 10, 2022
    K
    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083 (Dianhydrogalactitol)
    • Guangzhou, China
      Sun Yat-Sen University Cancer Center
    2022-03-23
    Mar 23, 2022
    K
    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2022-03-23
    Mar 23, 2022
    W
    Not yet recruiting
    • Glioblastoma
    • Glioblastoma Multiforme
    • Sonobiopsy
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    2022-03-04
    Mar 4, 2022
    G
    Recruiting
    • Glioblastoma Multiforme
    • Philadelphia, Pennsylvania
      (unnamed)
    2022-03-14
    Mar 14, 2022
    E
    Recruiting
    • Glioblastoma Multiforme
    • Nashville, Tennessee
      Sarah Cannon Research Institute (Tennessee Oncology)
    2022-03-14
    Mar 14, 2022
    C
    Recruiting
    • Glioblastoma Multiforme
    • Los Angeles, California
      Cedars-Sinai Medical Center
    2022-02-24
    Feb 24, 2022